HAVISURE VACCINE - SCI
& TECH
News: India's first indigenously
developed Hepatitis A vaccine launched in Hyderabad
What's in the news?
●
Recently, Indian Immunologicals Ltd (IIL), a wholly
owned subsidiary of the National Dairy Development Board (NDDB), has launched
India’s first domestically developed Hepatitis A vaccine, named ‘Havisure.’
Havisure Vaccine:
●
It is India’s
first indigenously developed vaccine for Hepatitis A.
Dosage:
●
It is a two-dose
vaccine.
●
The first dose given to those above 12 months of age and the second dose is administered at least
six months later.
Eligibility for Vaccine:
●
The vaccine is advised for routine immunization in children and individuals at risk due to exposure or travel to regions with
high hepatitis A prevalence.
●
Additionally, individuals with occupational
infection risks and those suffering from chronic livler diseases can also
receive Hepatitis A vaccination.
Significance:
●
This vaccine is expected to play a significant role
in preventing Hepatitis A.
●
Hepatitis A is a highly contagious liver infection
transmitted through contaminated food or water.
Go back to basics:
Hepatitis A:
●
It is a viral
infection that primarily causes inflammation
of the liver.
●
It can be an acute (short-term) infection or a
chronic (long-term) infection.
Transmission:
●
It is transmitted through the consumption of
contaminated food or water or through close contact with an infected person.
Symptoms:
●
The symptoms include fever, fatigue, nausea,
abdominal pain, and jaundice (yellowing of the skin and eyes).
Treatment:
●
As per WHO there is no specific treatment for hepatitis A.
●
Recovery from symptoms following infection may be
slow and can take several weeks or months.